![Renejix CDMO Partner for Small Molecule Oral Dosage Forms](https://www.pharmacompass.com/image/flap/renejix-w35-desktop-header-01gif-33629.gif)
![Renejix CDMO Partner for Small Molecule Oral Dosage Forms](https://www.pharmacompass.com/image/flap/renejix-w35-mob-header-01gif-17728.gif)
01 ATG-AS ACTIVE PHARMACEUTICAL INGREDIENT (1)
02 DPC 1528 (OLIGONUCLEOTIDE ARM), API (1)
03 HYDROXYSULPHONE FC4010 (1)
04 NFKB (OLIGONUCLEOTIDE ATO) ACTIVE PHARMACEUTICAL INGREDIENT (API) (1)
05 OLIGONUCLEOTIDE 2006 ACTIVE PHARMACEUTICAL INGREDIENT (1)
06 OLIGONUCLEOTIDE ANV (1)
07 OLIGONUCLEOTIDE APH (1)
08 OLIGONUCLEOTIDE APO (1)
09 OLIGONUCLEOTIDE APQ (1)
10 OLIGONUCLEOTIDE MG98 API (1)
11 OLIGONUCLEOTIDES (1)
12 ORI-1001 DRUG SUBSTANCE (1)
13 SDM-25 (25/75 ISOSORBIDE DINITRATE-MANNITOL MIXTURE) (1)
14 SDM-40 (25% ISOSORBIDE DINITRATE IN LACTOSE) (1)
15 SDM-47 (10/90 NITROGLYCERIN-PLASTISOL MIXTURE) (1)
16 SDM-75 (20 % NITROGLYCERIN IN SOLVATED ACRYLATE POLYMER) (1)
17 SDM-79 (25% NITROGLYCERIN IN SOLVATED ADHESIVE POLYMER) (1)
01 AVECIA BIOTECHNOLOGY INC (7)
02 AVECIA INC (5)
03 AVECIA PHARMACEUTICALS (1)
04 NITTO DENKO AVECIA INC (1)
05 NITTO DENKO CORP (3)
01 Japan (2)
02 U.S.A (15)
01 Inactive (17)
01 Blank (17)